At the Winship Cancer Institute, patients receive state-of-the-art therapies while scientists in the same building explore the frontiers of molecular biology.

More than 200 faculty members are engaged in moving discoveries from the benchtop to the bedside. Their work encompasses cancer prevention, oncology, pediatric oncology, molecular therapy, immunology and cancer genetics.

Several shared core facilities provide advanced technology services open to investigators throughout Emory.

Press Releases

• Lung Cancer Cells' Survival Gene Seen as Drug Target (1/3/08)
  
• Novel Anti-Cancer Targeting Strategy Yields Promising Results in Animal Tests (1/3/08)
  
• Gold Nanoparticle Probes May Allow Earlier Cancer Detection (12/28/07)
  
• "GPS" Improves Precision in Radiation Treatment for Prostate Tumors (12/17/07)
  
• Researchers Compute Total Body Radiation Received During Mammograms (12/12/07)
  
• New Mammography Technology Improves Cancer Detection (11/28/07)

Research, Education and Patient Care Links

• Winship Cancer Institute
  
• Emory-Georgia Tech Center for Cancer Nanotechnology
  
• Lung Cancer Research Program at Emory
  
• Cancer Genetics Program at Emory
  
• Prostate Cancer at Emory Healthcare
  
• Breast Cancer at Emory Healthcare

General Contact Information

Winship Cancer Institute
1365C Clifton Road
Atlanta, Georgia 30322
1-888-WINSHIP
cancer.emory.edu

Media Contact

Vincent J. Dollard
Director, Public Relations, Winship Cancer Institute
404-778-4580
vincent_dollard@emoryhealthcare.org

Emory scientists are working on innovative ways to detect cancer through nanotechnology and identifying new medications that could specifically target tumor cells without the side effects of conventional chemotherapies.

Director

Brian Leyland-Jones, MD, PhD
Director
Winship Cancer Institute

Biography